Manager / Senior Manager of EMR Integrations & Interoperability

Remote

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Molecular Diagnostics, Healthcare, Biotechnology, Precision MedicineIndustries

Requirements

Candidates must possess at least 6 years of experience in healthcare IT, EMR integration, or clinical interoperability, with a minimum of 2-3 years in a leadership capacity. Strong technical expertise in major EMR platforms and interoperability standards such as HL7, FHIR, CDA, SMART on FHIR, and APIs is required, along with a proven ability to deliver complex integration projects successfully.

Responsibilities

The Manager/Senior Manager of EMR Integrations & Interoperability will define and execute the enterprise-wide EMR integration strategy, develop the roadmap for integration infrastructure, and manage the full lifecycle of EMR integrations across major platforms. This role involves leading and mentoring a team of integration engineers, overseeing technical execution, ensuring security and compliance, and collaborating with cross-functional teams to align integration efforts with business objectives.

Skills

EMR Integrations

Interoperability

Healthcare IT

EMR Systems

Project Management

Clinical Workflows

Operational Efficiency

Product Management

Engineering

Clinical Operations

Commercial Teams

Technical Execution

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free